The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book


lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book


Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
Springer Nature



A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience



Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica


Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc


Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4



Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York


Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.


Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library


The rs599839 A>G variant disentangles cardiovascular risk and hepatocellular carcinoma in NAFLD patients

Meroni M,  Longo M, Paolini E, Alisi A, Miele L, De Caro ER, Pisano G, Maggioni M, Soardo G, Valenti L, Fracanzani AL, Dongiovanni P

Cancers (Basel). 2021 Apr 8;13(8):1783. doi: 10.3390/cancers13081783


DNA damage response protein CHK2 regulates metabolism in liver cancer

Lulli M, Del Coco L, Mello T, Sukowati C, Madiai S, Gragnani L, Forte P, Fanizzi FP, Mazzocca A, Rombouts K, Galli A, Carloni V

Cancer Res. 2021 Mar 24:canres.3134.2020. doi: 10.1158/0008-5472.CAN-20-3134


Life-long hyperbilirubinemia exposure and bilirubin priming prevent in vitro metabolic damage

Bianco A, Pinci S, Tiribelli C, Bellarosa C

Front Pharmacol. 2021 Mar 12;12:646953. doi: 10.3389/fphar.2021.646953


X chromosome contribution to the genetic architecture of primary biliary cholangitis

Asselta R, Paraboschi EM, Gerussi A, Cordell HJ, Mells GF, Sandford RN, Jones DE, Nakamura M, Ueno K, Hitomi Y, Kawashima M, Nishida N, Tokunaga K, Nagasaki M, Tanaka A, Tang R, Li Z, Shi Y, Liu X, Xiong M, Hirschfield G, Siminovitch KA; Canadian-US PBC Consortium; Italian PBC Genetics Study Group (including Tiribelli C); UK-PBC Consortium; Japan PBC-GWAS Consortium, Carbone M, Cardamone G, Duga S, Gershwin ME, Seldin MF, Invernizzi P

Gastroenterology 2021 Mar 3;S0016-5085(21)00466-2. doi: 10.1053/j.gastro.2021.02.061


Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, … including Bellarosa C

Autophagy. 2021 Feb 8;1-382. doi: 10.1080/15548627.2020.1797280.


Curcumin prevents cerebellar hypoplasia and restores the behavior in hyperbilirubinemic Gunn rat by a pleiotropic effect on the molecular effectors of brain damage

Gazzin S, Dal Ben M, Montrone M, Jayanti S, Lorenzon A, Bramanate A, Bottin C, Moretti R, Tiribelli C

Int J Mol Sci. 2020 Dec 30;22(1):299. doi: 10.3390/ijms22010299


The mRNA distribution of cancer stem cells marker CD90/Thy-1 is comparable in hepatocellular carcinoma of Eastern and Western populations

Luong AB, Do HQ, Tarchi P, Bonazza D, Bottin C, Cabral LKD, Tran LDC, Doan TPT, Crocè LS, Pham HLT, Tiribelli C, Sukowati CHC

Cells. 2020 Dec 12;9(12):2672. doi: 10.3390/cells9122672


BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: A systematic review

Cabas P, Rizzo M, Giuffrè M, Antonello RM, Trombetta C, Luzzati R, Liguori G, Di Bella S

Urol Oncol. 2020 Dec 8:S1078-1439(20)30624-4. doi: 10.1016/j.urolonc.2020.11.037


Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, Santoro L, Maier S, Liguori A, Meroni M, Borroni V, D'Ambrosio R, Spagnuolo R, Alisi A, Federico A, Bugianesi E, Petta S, Miele L, Vespasiani-Gentilucci U, Anstee QM, Stickel F, Hampe J, Fischer J, Berg T, Fracanzani AL, Soardo G, Reeves H, Prati D, Romeo S, Valenti L

J Hepatol. S0168-8278(20)33811-3. doi: 10.1016/j.jhep.2020.11.024.


Changes of body weight and body composition in obese patients with Prader-Willi Syndrome at 3 and 6 years of follow-up: A retrospective cohort study

Bedogni G, Grugni G, Cicolini S, Caroli D, Tamini S, Sartorio A

J Clin Med. 9(11):E3596. doi: 10.3390/jcm9113596.


Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      


Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643


Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359


New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027


Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.


Treatments for non-alcoholic steatohepatitis - still a long way to go

 Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)


Basal ganglia: Their role in complex cognitive procedures in experimental models and in clinical practice

Moretti R, Caruso P, Crisman E, Gazzin S

Neurol India. Jul-Aug;65(4):814-825. doi: 10.4103/neuroindia.NI_850_16


Is it time to change NAFLD and NASH nomenclature?

Bellentani S, Tiribelli C

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):547-548. doi: 10.1016/S2468-1253(17)30146-2


Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health

Martini D, Rossi S, Biasini B, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Di Nuzzo S, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Del Rio D

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):473-503. doi: 10.1016/j.numecd.2017.01.008. Epub 2017 Feb 13


The molecular basis of jaundice: An old symptom revisited

Gazzin S, Masutti F, Vitek L, Tiribelli C

Liver Int. doi: 10.1111/liv.13351.